Analysis of human serum by liquid chromatography-mass spectrometry: Improved sample preparation and data analysis

被引:57
作者
Govorukhina, N. I.
Reijmers, T. H.
Nyangoma, S. O.
van der Zee, A. G. J.
Jansen, R. C.
Bischoff, R.
机构
[1] Univ Groningen, Ctr Pharm, Dept Analyt Biochem, NL-9713 AV Groningen, Netherlands
[2] Univ Groningen, Med Ctr, Dept Gynecol, NL-9713 AV Groningen, Netherlands
[3] Univ Groningen, Groningen Bioinformat Ctr, NL-9751 NN Haren, Netherlands
关键词
proteomics; mass spectrometry; biomarker; HPLC; cervical cancer;
D O I
10.1016/j.chroma.2006.02.088
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Discovery of biomarkers is a fast developing field in proteomics research. Liquid chromatography coupled on line to mass spectrometry (LC-MS) has become a powerful method for the sensitive detection, quantification and identification of proteins and peptides in biological fluids like serum. However, the presence of highly abundant proteins often masks those of lower abundance and thus generally prevents their detection and identification in proteomics studies. To perform future comparative analyses of samples from a serum bank of cervical cancer patients in a longitudinal and cross-sectional manner, methodology based on the depletion of high-abundance proteins followed by tryptic digestion and LC-MS has been developed. Two sample preparation methods were tested in terms of their efficiency to deplete high-abundance serum proteins and how they affect the repeatability of the LC-MS data sets. The first method comprised depletion of human serum albumin (HSA) on a dye ligand chromatographic and immunoglobulin G (IgG) on an immobilized Protein A support followed by tryptic digestion, fractionation by cation-exchange chromatography, trapping on a C18 column and reversed-phase LC-MS. The second method included depletion of the six most abundant serum proteins based on multiple immunoaffinity chromatography followed by tryptic digestion, trapping on a C 18 column and reversed-phase LC-MS. Repeatability of the overall procedures was evaluated in terms of retention time and peak area for a selected number of endogenous peptides showing that the second method, besides being less time consuming, gave more repeatable results (retention time: < 0.1% RSD; peak area: < 30% RSD). Application of an LC-MS component detection algorithm followed by principal component analysis (PCA) enabled discrimination of serum samples that were spiked with horse heart cytochrome C from non-spiked serum and the detection of a concentration trend, which correlated to the amount of spiked horse heart cytochrome C to a level of 5 pmol cytochrome C in 2 mu l original serum. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:142 / 150
页数:9
相关论文
共 32 条
[1]  
AKERSTROM B, 1985, J IMMUNOL, V135, P2589
[2]  
Ardekani Ali M, 2002, Expert Rev Mol Diagn, V2, P312, DOI 10.1586/14737159.2.4.312
[3]   Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples [J].
Björhall, K ;
Miliotis, T ;
Davidsson, P .
PROTEOMICS, 2005, 5 (01) :307-317
[4]   Global internal standard technology for comparative proteomics [J].
Chakraborty, A ;
Regnier, FE .
JOURNAL OF CHROMATOGRAPHY A, 2002, 949 (1-2) :173-184
[5]   Beyond expansion: Structural studies on the transport roles of human serum albumin [J].
Curry, S .
VOX SANGUINIS, 2002, 83 :315-319
[6]   Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and clCAT with multidimensional liquid chromatography and tandem mass spectrometry [J].
DeSouza, L ;
Diehl, G ;
Rodrigues, MJ ;
Guo, JZ ;
Romaschin, AD ;
Colgan, TJ ;
Siu, KWM .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (02) :377-386
[7]   Proteomic patterns to identify ovarian cancer: 3 years on [J].
Diamandis, EP .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (05) :575-577
[8]   OvaCheck: doubts voiced soon after publication [J].
Diamandis, EP .
NATURE, 2004, 430 (7000) :611-611
[9]   Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer [J].
Esajas, MD ;
Duk, JM ;
de Bruijn, HWA ;
Aalders, JG ;
Willemse, PHB ;
Sluiter, W ;
Pras, B ;
ten Hoor, K ;
Hollema, H ;
van der Zee, AGJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) :3960-3966
[10]   Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs [J].
Fortier, MH ;
Bonneil, E ;
Goodley, P ;
Thibault, P .
ANALYTICAL CHEMISTRY, 2005, 77 (06) :1631-1640